Old Web
English
Sign In
Acemap
>
authorDetail
>
KA Papp
KA Papp
Bimekizumab
Medicine
in patient
Internal medicine
plaque psoriasis
3
Papers
3
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Bimekizumab Efficacy and Safety versus Adalimumab in Patients with Moderate to Severe Plaque Psoriasis: Results from a Multicenter, Randomized, Double-Blinded Active Comparator-Controlled Phase 3 Trial (BE SURE)
2021
Richard B. Warren
A. Blauvelt
J. Bagel
KA Papp
P. Yamauchi
April W. Armstrong
R. Langley
V. Vanvoorden
D. De Cuyper
L Peterson
N. Cross
K. Reich
Show All
Source
Cite
Save
Citations (3)
Bimekizumab for the Treatment of Moderate to Severe Plaque Psoriasis with Scalp, Nail and Palmoplantar Involvement Through 52 Weeks: Post-Hoc Analysis from the BE VIVID Phase 3 Trial
2021
KA Papp
Mark Lebwohl
AB Gottlieb
M Sebastián
R. Langley
Y. Okubo
M. Wang
Christopher Cioffi
F. Staelens
K. Reich
Show All
Source
Cite
Save
Citations (0)
1